Cargando…

Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential

Pancreatic Ductal Adenocarcinoma (PDAC) is a highly lethal malignancy that responds poorly to current therapeutic modalities. In an effort to develop novel therapeutic strategies, we found downregulation of miR-29 in pancreatic cancer cells, and overexpression of miR-29a sensitized chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwon, Jason J., Willy, Jeffrey A., Quirin, Kayla A., Wek, Ronald C., Korc, Murray, Yin, Xiao-Ming, Kota, Janaiah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342107/ https://www.ncbi.nlm.nih.gov/pubmed/27626694 http://dx.doi.org/10.18632/oncotarget.11928

Ejemplares similares

A Systematic Review of miR-29 in Cancer
por: Kwon, Jason J., et al.
Publicado: (2018)

Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis
por: Dey, Shatovisha, et al.
Publicado: (2021)

Pathophysiological role of microRNA-29 in pancreatic cancer stroma
por: Kwon, Jason J., et al.
Publicado: (2015)

Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice
por: Quirin, Kayla A., et al.
Publicado: (2017)

Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment
por: Dey, Shatovisha, et al.
Publicado: (2020)

Gene targets of mouse miR-709: regulation of distinct pools
por: Surendran, Sneha, et al.
Publicado: (2016)

The Role and Therapeutic Potential of miRNAs in Colorectal Liver Metastasis
por: Sahu, Smiti S., et al.
Publicado: (2019)

Recombinant pre-miR-29b for Alzheimer´s disease therapeutics
por: Pereira, Patrícia A., et al.
Publicado: (2016)

Dynamic Alterations to Hepatic MicroRNA-29a in Response to Long-Term High-Fat Diet and EtOH Feeding
por: Liang, Tiebing, et al.
Publicado: (2023)

Beyond Kras: MYC Rules in Pancreatic Cancer
por: Korc, Murray
Publicado: (2018)

The role of miR‐29 family in disease
por: Horita, Masahiro, et al.
Publicado: (2021)

Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer
por: Deharvengt, Sophie, et al.
Publicado: (2012)

miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
por: Amodio, Nicola, et al.
Publicado: (2015)

Heparin Prowess: Favorable Vascular–Immune Reprogramming in Pancreatic Cancer
por: Korc, Murray
Publicado: (2023)

Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia
por: Xu, Ling, et al.
Publicado: (2014)

Sugar-Coated Proteins Pave the Way to Improving Pancreatic Cancer Diagnosis
por: Korc, Murray
Publicado: (2016)

MiR-29a: a potential therapeutic target and promising biomarker in tumors
por: Wang, Jin-yan, et al.
Publicado: (2018)

miR-29a-deficiency does not modify the course of murine pancreatic acinar carcinoma
por: Dooley, James, et al.
Publicado: (2017)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

Pancreatic β cells control glucose homeostasis via the secretion of exosomal miR‐29 family
por: Li, Jing, et al.
Publicado: (2021)

Is miR-29 an oncogene or tumor suppressor in CLL?
por: Pekarsky, Yuri, et al.
Publicado: (2010)

MiR-29/Hsp47 in ECM network
por: Xu, Ren
Publicado: (2015)

The Role of miR-29s in Human Cancers—An Update
por: Nguyen, Thuy T. P., et al.
Publicado: (2022)

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
por: Ngankeu, Apollinaire, et al.
Publicado: (2017)

The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
por: Principe, Daniel R., et al.
Publicado: (2021)

Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice Expressing Oncogenic Kras in the Nestin Cell Lineage
por: Carrière, Catherine, et al.
Publicado: (2011)

Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer
por: Zhao, Xin, et al.
Publicado: (2018)

The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation
por: Gasque Schoof, Cláudia Regina, et al.
Publicado: (2015)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China
por: He, Xin, et al.
Publicado: (2022)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
por: Bayat, Parisa, et al.
Publicado: (2022)

Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype
por: Jiang, Jianxin, et al.
Publicado: (2014)

MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1
por: Lu, Yebin, et al.
Publicado: (2015)

Methylation of the miR-29b-3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer
por: Wang, Lihua, et al.
Publicado: (2021)

MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer
por: Mo, Wen-Yan, et al.
Publicado: (2022)

MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer
por: Xu, Hui, et al.
Publicado: (2020)

Autophagy-Related Activation of Hepatic Stellate Cells Reduces Cellular miR-29a by Promoting Its Vesicular Secretion
por: Yu, Xiaojie, et al.
Publicado: (2022)

miR-29b and miR-29c Are Involved in Toll-Like Receptor Control of Glucocorticoid-Induced Apoptosis in Human Plasmacytoid Dendritic Cells
por: Hong, Yongfeng, et al.
Publicado: (2013)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus
por: Hezova, Renata, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j5lctckr6ke5nss1iued7tc0ui